United States

Bio Rad Laboratories Inc (BIO)

BIO on New York Consolidated

24 Jan 2017
Change (% chg)

$-0.82 (-0.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Bio Rad Laboratories reports Q2 profit $0.61 per share
Wednesday, 3 Aug 2016 04:15pm EDT 

Bio Rad Laboratories Inc : Second-Quarter reported revenues were $516.8 million, an increase of 2.1 percent . Bio-Rad reports second-quarter 2016 financial results .Net income for Q2 of 2016 was $18.0 million, or $0.61 per share.  Full Article

Bio-Rad Laboratories Inc's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets
Monday, 21 Dec 2015 04:21pm EST 

Bio-Rad Laboratories:Received U.S. Food and Drug Administration clearance to market its TANGO infinity system in the U.S.The system automates routine blood typing and screening testing procedures for patients and donors.  Full Article

Bio-Rad Laboratories Inc announces U.S. FDA pre-market approval for BioPlex 2200 HIV Ag-Ab Assay
Tuesday, 28 Jul 2015 04:15pm EDT 

Bio-Rad Laboratories Inc:Received U.S. Food and Drug Administration pre-market approval to offer its BioPlex 2200 HIV Ag-Ab assay, the company's 5th generation HIV diagnostic test.  Full Article